Information  X 
Enter a valid email address

Globo plc (GBO)

  Print          Annual reports

Tuesday 30 December, 2014

Globo plc

Globo to participate in European mHealth project

RNS Number : 8726A
Globo plc
30 December 2014

FOR IMMEDIATE RELEASE                                                              30th December 2014




("Globo" or the "Group")


Globo to participate in European mHealth research project



Globo plc (LSE-AIM: GBO), the international provider of enterprise mobility management solutions and software as a service, has been selected to participate in a consortium of European Universities and companies* which has been awarded an European Union Framework Programme grant of 4.3 million for research into Parkinson's Disease (PD) management using mobile-health (mHealth) technology.


The PD manager programme will use unobtrusive mobile devices to capture data from the onset of symptoms in patients, such as tremor, posture imbalance or speech and cognitive changes. It will also be able to input data from the carer via a smartphone. The resulting data will be collated and used to build a care decision support platform which will help improve medication provision, a key factor for increasing independence and quality of life for patients.  The PD knowledge management platform will be built with a cloud-based, open architecture approach, supporting the use of any commercial set of sensors and based on the Internet of Things concept.


The evaluation of the programme will be based on 230 patient studies. One important outcome will be the evaluation of the use of mobile apps for the development of new approaches to clinical care, looking at the impact on quality of life, care efficiency and potential economic benefits. Globo will support the research, offering  its GO!Enterprise technology with a view to potentially expand the resulting product and systems beyond the PD manager programme.  Globo also intends to support  the commercialisation of the product.  Globo's specific element of the programme will receive 300,000 in funding.


(* including: Fondazione Ospedale San Camillo IT; Institut Jozef Stefan SI; Biotronics 3D Ltd.; Universidad Politecnica de Madrid ES; University of Surrey; Moticon DE).


Globo's CEO, Costis Papadimitrakopoulos, commented:


"Globo is proud to have been selected to participate in this high-profile programme. This exciting project complements our ambitions in the emerging field of mHealth, illustrates the trust placed in the underlying security and consistency of our technology, and demonstrates the applicability of the GO!Enterprise platform to systems based on the Internet of Things." 






Globo plc

+44 20-7378-8828

Costis Papadimitrakopoulos, CEO

Dimitris Gryparis, Finance Director

Mike Jeremy, IRO

RBC Capital Markets

(Nominated Adviser & Broker)

+44 20-7653-4000

Pierre Schreuder

Canaccord Genuity

(Joint Broker)

Simon Bridges or Emma Gabriel

+44 20-7523-8000


Brunswick Group

Chris Blundell or Katarina Sallerfors

+44 20-7404-5959


About Globo plc

Globo Plc is a global provider of complete enterprise mobility solutions and SaaS. Our GO!Enterprise (EMM) and GO!AppZone (MADP) offerings help businesses expand their engagement with employees and customers through the mobile channel via a secure and extensible environment that runs on all smart devices. The Group operates internationally through subsidiaries and offices in U.S., U.K., Europe, Middle East and South East Asia. Globo was recognised in the 2014 Gartner Enterprise Mobility Management Magic Quadrant report and in Ovum's 2014-15 Decision Matrix for EMM Solutions.


For more information visit

This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t